Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Fisher, DE
   The p53 tumor suppressor: Critical regulator of life & death in cancer
   APOPTOSIS
   
   D.E. Fisher, "The p53 tumor suppressor: Critical regulator of life & death in cancer", APOPTOSIS, 6(1-2), 2001, pp. 7-15
2. Lutzker, SG; Lattime, EC
   Use of dendritic cells to immunize against cancers overexpressing p53
   CLINICAL CANCER RESEARCH
   
   S.G. Lutzker e E.C. Lattime, "Use of dendritic cells to immunize against cancers overexpressing p53", CLIN CANC R, 7(1), 2001, pp. 2-4
3. Ali, SH; DeCaprio, JA
   Cellular transformation by SV40 large T antigen: interaction with host proteins
   SEMINARS IN CANCER BIOLOGY
   
   S.H. Ali e J.A. DeCaprio, "Cellular transformation by SV40 large T antigen: interaction with host proteins", SEM CANC B, 11(1), 2001, pp. 15-22
4. Imperiale, MJ; Pass, HI; Sanda, MG
   Prospects for an SV40 vaccine
   SEMINARS IN CANCER BIOLOGY
   
   M.J. Imperiale et al., "Prospects for an SV40 vaccine", SEM CANC B, 11(1), 2001, pp. 81-85
5. Giannakakou, P; Robey, R; Fojo, T; Blagosklonny, MV
   Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity
   ONCOGENE
   
   P. Giannakakou et al., "Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity", ONCOGENE, 20(29), 2001, pp. 3806-3813
6. Huo, TI; Wang, XW; Forgues, M; Wu, CG; Spillare, EA; Giannini, C; Brechot, C; Harris, CC
   Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis
   ONCOGENE
   
   T.I. Huo et al., "Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis", ONCOGENE, 20(28), 2001, pp. 3620-3628
7. Weiss, RH; Howard, LL
   p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque
   CELLULAR SIGNALLING
   
   R.H. Weiss e L.L. Howard, "p73 is a growth-regulated protein in vascular smooth muscle cells and is present at high levels in human atherosclerotic plaque", CELL SIGNAL, 13(10), 2001, pp. 727-733
8. Robles, AI; Harris, CC
   p53-mediated apoptosis and genomic instability diseases
   ACTA ONCOLOGICA
   
   A.I. Robles e C.C. Harris, "p53-mediated apoptosis and genomic instability diseases", ACTA ONCOL, 40(6), 2001, pp. 696-701
9. Utermohlen, O; Schulze-Garg, C; Warnecke, G; Gugel, R; Lohler, J; Deppert, W
   Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells
   JOURNAL OF VIROLOGY
   
   O. Utermohlen et al., "Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells", J VIROLOGY, 75(22), 2001, pp. 10593-10602
10. Nakamura, H; Li, M; Zarycki, J; Jung, JU
    Inhibition of p53 tumor suppressor by viral interferon regulatory factor
    JOURNAL OF VIROLOGY
    
    H. Nakamura et al., "Inhibition of p53 tumor suppressor by viral interferon regulatory factor", J VIROLOGY, 75(16), 2001, pp. 7572-7582
11. Collins, LL; Lin, DL; Mu, XM; Chang, CS
    Feedback regulation between orphan nuclear receptor TR2 and human papilloma virus type 16
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    L.L. Collins et al., "Feedback regulation between orphan nuclear receptor TR2 and human papilloma virus type 16", J BIOL CHEM, 276(29), 2001, pp. 27316-27321
12. Strano, S; Rossi, M; Fontemaggi, G; Munarriz, E; Soddu, S; Sacchi, A; Blandino, G
    From p63 to p53 across p73
    FEBS LETTERS
    
    S. Strano et al., "From p63 to p53 across p73", FEBS LETTER, 490(3), 2001, pp. 163-170
13. Guiducci, C; Anglana, M; Wang, A; Bacchetti, S
    Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells
    EXPERIMENTAL CELL RESEARCH
    
    C. Guiducci et al., "Transient expression of wild-type or biologically inactive telomerase allows the formation of artificial telomeres in mortal human cells", EXP CELL RE, 265(2), 2001, pp. 304-311
14. Asamoto, M; Hokaiwado, N; Cho, YM; Takahashi, S; Ikeda, Y; Imaida, K; Shirai, T
    Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent
    CANCER RESEARCH
    
    M. Asamoto et al., "Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent", CANCER RES, 61(12), 2001, pp. 4693-4700
15. Laderoute, KR; Calaoagan, JM; Knapp, AM; Mendonca, HL; Johnson, RS
    c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    K.R. Laderoute et al., "c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells", BIOC BIOP R, 284(5), 2001, pp. 1134-1139
16. Gillet, R; Cavard, C; Grimber, G; Briand, P; Joulin, V
    Hepatic expression of SV40 small-t antigen blocks the in vivo CD95-Mediated apoptosis
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    R. Gillet et al., "Hepatic expression of SV40 small-t antigen blocks the in vivo CD95-Mediated apoptosis", BIOC BIOP R, 284(2), 2001, pp. 369-376
17. Greenberg, NM
    Androgens and growth factors in prostate cancer: a transgenic perspective
    PROSTATE CANCER AND PROSTATIC DISEASES
    
    N.M. Greenberg, "Androgens and growth factors in prostate cancer: a transgenic perspective", PROSTATE C, 3(4), 2000, pp. 224-228
18. Snawder, JE; Savage, RE; Swaminathan, S; Frederickson, SM; Reznikoff, CA
    Characterization of cytochrome P450-dependent and glutathione transferase activities in SV40-immortalized uroepithelial cell lines: Possible role in transformation and tumor formation
    TOXICOLOGY METHODS
    
    J.E. Snawder et al., "Characterization of cytochrome P450-dependent and glutathione transferase activities in SV40-immortalized uroepithelial cell lines: Possible role in transformation and tumor formation", TOX METHOD, 10(3), 2000, pp. 195-201
19. Smith, LS; Tachibana, I; Lee, HK; Qian, JQ; Pohl, U; Mohrenweiser, HW; Borell, TJ; Hosek, SM; Soderberg, CL; von Deimling, A; Perry, A; Scheithauer, BW; Louis, DN; Jenkins, RB
    Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers
    GENES CHROMOSOMES & CANCER
    
    L.S. Smith et al., "Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers", GENE CHROM, 29(1), 2000, pp. 16-25
20. McCormick, F
    Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015
    SEMINARS IN CANCER BIOLOGY
    
    F. McCormick, "Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015", SEM CANC B, 10(6), 2000, pp. 453-459
21. Gao, JP; Uchida, T; Wang, CX; Jiang, SX; Matsumoto, K; Satoh, T; Minei, S; Soh, S; Kameya, T; Baba, S
    Relationship between p53 gene mutation and protein expression: Clinical significance in transitional cell carcinoma of the bladder
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    J.P. Gao et al., "Relationship between p53 gene mutation and protein expression: Clinical significance in transitional cell carcinoma of the bladder", INT J ONCOL, 16(3), 2000, pp. 469-475
22. Varma, H; Conrad, SE
    Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain
    ONCOGENE
    
    H. Varma e S.E. Conrad, "Reversal of an antiestrogen-mediated cell cycle arrest of MCF-7 cells by viral tumor antigens requires the retinoblastoma protein-binding domain", ONCOGENE, 19(41), 2000, pp. 4746-4753
23. Miyata, Y; Yahara, I
    p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90
    ONCOGENE
    
    Y. Miyata e I. Yahara, "p53-independent association between SV40 large T antigen and the major cytosolic heat shock protein, HSP90", ONCOGENE, 19(11), 2000, pp. 1477-1484
24. Ichikawa, A
    Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    A. Ichikawa, "Prognostic and predictive significance of p53 mutation in aggressive B-cell lymphoma", INT J HEMAT, 71(3), 2000, pp. 211-220
25. Bowman, KK; Sicard, DM; Ford, JM; Hanawalt, PC
    Reduced global genomic repair of ultraviolet light-induced cyclobutane pyrimidine dimers in simian virus 40-transformed human cells
    MOLECULAR CARCINOGENESIS
    
    K.K. Bowman et al., "Reduced global genomic repair of ultraviolet light-induced cyclobutane pyrimidine dimers in simian virus 40-transformed human cells", MOL CARCINO, 29(1), 2000, pp. 17-24
26. Shin, MK
    Controlling gene expression in mice with tetracycline: Application in pigment cell research
    PIGMENT CELL RESEARCH
    
    M.K. Shin, "Controlling gene expression in mice with tetracycline: Application in pigment cell research", PIGM CELL R, 13(5), 2000, pp. 326-331
27. Blagosklonny, MV
    p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect
    FASEB JOURNAL
    
    M.V. Blagosklonny, "p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect", FASEB J, 14(13), 2000, pp. 1901-1907
28. Fojta, M; Brazdova, M; Cernocka, H; Pecinka, P; Brazda, V; Palecek, J; Jagelska, E; Vojtesek, B; Pospisilova, S; Subramaniam, V; Jovin, TM; Palecek, E
    Effects of oxidation agents and metal ions on binding of p53 to supercoiled DNA
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
    
    M. Fojta et al., "Effects of oxidation agents and metal ions on binding of p53 to supercoiled DNA", J BIO STRUC, 2000, pp. 177-183
29. Marin, MC; Kaelin, WG
    p63 and p73: Old members of a new family
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    
    M.C. Marin e W.G. Kaelin, "p63 and p73: Old members of a new family", BBA-REV CAN, 1470(3), 2000, pp. M93-M100
30. Liu, Y; Colosimo, AL; Yang, XJ; Liao, DQ
    Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF
    MOLECULAR AND CELLULAR BIOLOGY
    
    Y. Liu et al., "Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF", MOL CELL B, 20(15), 2000, pp. 5540-5553
31. Sullivan, CS; Tremblay, JD; Fewell, SW; Lewis, JA; Brodsky, JL; Pipas, JM
    Species-specific elements in the large T-antigen J domain are required forcellular transformation and DNA replication by simian virus 40
    MOLECULAR AND CELLULAR BIOLOGY
    
    C.S. Sullivan et al., "Species-specific elements in the large T-antigen J domain are required forcellular transformation and DNA replication by simian virus 40", MOL CELL B, 20(15), 2000, pp. 5749-5757
32. Ghosh, SS; Takahashi, M; Thummala, NR; Parashar, B; Chowdhury, NR; Chowdhury, JR
    Liver-directed gene therapy: promises, problems and prospects at the turn of the century
    JOURNAL OF HEPATOLOGY
    
    S.S. Ghosh et al., "Liver-directed gene therapy: promises, problems and prospects at the turn of the century", J HEPATOL, 32, 2000, pp. 238-252
33. Butel, JS
    Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
    CARCINOGENESIS
    
    J.S. Butel, "Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease", CARCINOGENE, 21(3), 2000, pp. 405-426
34. Oldstone, MBA; Levine, AJ
    Virology in the next millennium
    CELL
    
    M.B.A. Oldstone e A.J. Levine, "Virology in the next millennium", CELL, 100(1), 2000, pp. 139-142
35. Sheng, Q; Love, TM; Schaffhausen, B
    J domain-independent regulation of the Rb family by polyomavirus large T antigen
    JOURNAL OF VIROLOGY
    
    Q. Sheng et al., "J domain-independent regulation of the Rb family by polyomavirus large T antigen", J VIROLOGY, 74(11), 2000, pp. 5280-5290
36. Strano, S; Munarriz, E; Rossi, M; Cristofanelli, B; Shaul, Y; Castagnoli, L; Levine, AJ; Sacchi, A; Cesareni, G; Oren, M; Blandino, G
    Physical and functional interaction between p53 mutants and different isoforms of p73
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S. Strano et al., "Physical and functional interaction between p53 mutants and different isoforms of p73", J BIOL CHEM, 275(38), 2000, pp. 29503-29512
37. Zeimet, AG; Riha, K; Berger, J; Widschwendter, M; Hermann, M; Daxenbichler, G; Marth, C
    New insights into p53 regulation and gene therapy for cancer
    BIOCHEMICAL PHARMACOLOGY
    
    A.G. Zeimet et al., "New insights into p53 regulation and gene therapy for cancer", BIOCH PHARM, 60(8), 2000, pp. 1153-1163
38. Oren, M; Rotter, V
    Introduction: p53 - the first twenty years
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    M. Oren e V. Rotter, "Introduction: p53 - the first twenty years", CELL MOL L, 55(1), 1999, pp. 9-11
39. Hupp, TR
    Regulation of p53 protein function through alterations in protein-folding pathways
    CELLULAR AND MOLECULAR LIFE SCIENCES
    
    T.R. Hupp, "Regulation of p53 protein function through alterations in protein-folding pathways", CELL MOL L, 55(1), 1999, pp. 88-95
40. McCormick, F
    Cancer therapy based on p53
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    
    F. McCormick, "Cancer therapy based on p53", CA J SCI AM, 5(3), 1999, pp. 139-144
41. Bellas, RE; Sonenshein, GE
    Nuclear factor kappa B cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function
    CELL GROWTH & DIFFERENTIATION
    
    R.E. Bellas e G.E. Sonenshein, "Nuclear factor kappa B cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function", CELL GROWTH, 10(5), 1999, pp. 287-294
42. Komiya, T; Hirashima, T; Kawase, I
    Clinical significance of p53 in non-small cell lung cancer (Review)
    ONCOLOGY REPORTS
    
    T. Komiya et al., "Clinical significance of p53 in non-small cell lung cancer (Review)", ONCOL REP, 6(1), 1999, pp. 19-28
43. Shimizu, T; Oga, A; Murakami, T; Muto, M
    Overexpression of p53 protein associated with proliferative activity and histological degree of malignancy in solar keratosis
    DERMATOLOGY
    
    T. Shimizu et al., "Overexpression of p53 protein associated with proliferative activity and histological degree of malignancy in solar keratosis", DERMATOLOGY, 199(2), 1999, pp. 113-118
44. Yap, DBS; Hsieh, JK; Chan, FSG; Lu, X
    mdm2: a bridge over the two tumour suppressors, p53 and Rb
    ONCOGENE
    
    D.B.S. Yap et al., "mdm2: a bridge over the two tumour suppressors, p53 and Rb", ONCOGENE, 18(53), 1999, pp. 7681-7689
45. Maroulakou, IG; Shibata, MA; Anver, M; Jorcyk, CL; Liu, ML; Roche, N; Roberts, AB; Tsarfaty, I; Reseau, J; Ward, J; Green, JE
    Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression
    ONCOGENE
    
    I.G. Maroulakou et al., "Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression", ONCOGENE, 18(39), 1999, pp. 5435-5447
46. Kuhn, C; Muller, F; Melle, C; Nasheuer, HP; Janus, F; Deppert, W; Grosse, F
    Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha
    ONCOGENE
    
    C. Kuhn et al., "Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha", ONCOGENE, 18(3), 1999, pp. 769-774
47. Phillips, HA
    The role of the p53 tumour suppressor gene in human breast cancer
    CLINICAL ONCOLOGY
    
    H.A. Phillips, "The role of the p53 tumour suppressor gene in human breast cancer", CL ONCOL-UK, 11(3), 1999, pp. 148-155
48. Strayer, DS; Zern, MA
    Gene delivery to the liver using simian virus 40-derived vectors
    SEMINARS IN LIVER DISEASE
    
    D.S. Strayer e M.A. Zern, "Gene delivery to the liver using simian virus 40-derived vectors", SEM LIV DIS, 19(1), 1999, pp. 71-81
49. Kappler, R; Pietsch, T; Weggen, S; Wiestler, OD; Scherthan, H
    Chromosomal imbalances and DNA amplifications in SV40 large T antigen-induced primitive neuroectodermal tumor cell lines of the rat
    CARCINOGENESIS
    
    R. Kappler et al., "Chromosomal imbalances and DNA amplifications in SV40 large T antigen-induced primitive neuroectodermal tumor cell lines of the rat", CARCINOGENE, 20(8), 1999, pp. 1433-1438
50. Nishikawa, T; Arai, S; Uobe, K; Wato, M; Tominaga, K; Masuno, K; Mori, M; Yoshida, S; Kobayashi, H; Tanaka, A
    A double staining method for histone H3 mRNA and p53 protein in oral tumors using in situ hybridization and immunohistochemistry
    ACTA HISTOCHEMICA ET CYTOCHEMICA
    
    T. Nishikawa et al., "A double staining method for histone H3 mRNA and p53 protein in oral tumors using in situ hybridization and immunohistochemistry", ACT HIST CY, 32(4), 1999, pp. 327-332
51. Zimmermann, H; Degenkolbe, R; Bernard, HU; O'Connor, MJ
    The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300
    JOURNAL OF VIROLOGY
    
    H. Zimmermann et al., "The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300", J VIROLOGY, 73(8), 1999, pp. 6209-6219
52. Prives, C; Hall, PA
    The P53 pathway
    JOURNAL OF PATHOLOGY
    
    C. Prives e P.A. Hall, "The P53 pathway", J PATHOLOGY, 187(1), 1999, pp. 112-126
53. Strayer, DA
    Gene therapy using SV40-derived vectors: What does the future hold?
    JOURNAL OF CELLULAR PHYSIOLOGY
    
    D.A. Strayer, "Gene therapy using SV40-derived vectors: What does the future hold?", J CELL PHYS, 181(3), 1999, pp. 375-384
54. Fang, L; Lee, SW; Aaronson, SA
    Comparative analysis of p73 and p53 regulation and effector functions
    JOURNAL OF CELL BIOLOGY
    
    L. Fang et al., "Comparative analysis of p73 and p53 regulation and effector functions", J CELL BIOL, 147(4), 1999, pp. 823-830
55. Freedman, DA; Levine, AJ
    Regulation of the p53 protein by the MDM2 oncoprotein - Thirty-eighth G.H.A. Clowes Memorial Award lecture
    CANCER RESEARCH
    
    D.A. Freedman e A.J. Levine, "Regulation of the p53 protein by the MDM2 oncoprotein - Thirty-eighth G.H.A. Clowes Memorial Award lecture", CANCER RES, 59(1), 1999, pp. 1-7
56. Kohli, M; Jorgensen, TJ
    The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    M. Kohli e T.J. Jorgensen, "The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses", BIOC BIOP R, 257(1), 1999, pp. 168-176
57. Kaelin, WG
    The emerging p53 gene family
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    W.G. Kaelin, "The emerging p53 gene family", J NAT CANC, 91(7), 1999, pp. 594-598
58. Xie, YC; Hwang, C; Overwijk, W; Zeng, Z; Eng, MH; Mule, JJ; Imperiale, MJ; Restifo, NP; Sanda, MG
    Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    Y.C. Xie et al., "Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen", J NAT CANC, 91(2), 1999, pp. 169-175
59. ROBERTS RA
    CURRENT ISSUES IN MUTAGENESIS AND CARCINOGENESIS, NO. 85 - TRANSGENICRODENT MUTATION CANCER BIOASSAYS - CELL-CYCLE CONTROL, CELL-PROLIFERATION AND APOPTOSIS AS MODIFIERS OF OUTCOME
    Mutation research. Fundamental and molecular mechanisms of mutagenesis
    
    R.A. Roberts, "CURRENT ISSUES IN MUTAGENESIS AND CARCINOGENESIS, NO. 85 - TRANSGENICRODENT MUTATION CANCER BIOASSAYS - CELL-CYCLE CONTROL, CELL-PROLIFERATION AND APOPTOSIS AS MODIFIERS OF OUTCOME", Mutation research. Fundamental and molecular mechanisms of mutagenesis, 398(1-2), 1998, pp. 189-195
60. VANRENSBURG EJ; ENGELBRECHT S; VANHEERDEN WFP; KOTZE MJ; RAUBENHEIMER EJ
    DETECTION OF P53 GENE-MUTATIONS IN ORAL SQUAMOUS-CELL CARCINOMAS OF ABLACK-AFRICAN POPULATION-SAMPLE
    Human mutation
    
    E.J. Vanrensburg et al., "DETECTION OF P53 GENE-MUTATIONS IN ORAL SQUAMOUS-CELL CARCINOMAS OF ABLACK-AFRICAN POPULATION-SAMPLE", Human mutation, 11(1), 1998, pp. 39-44
61. VANRENSBURG EJ; ENGELBRECHT S; VANHEERDEN WFP; KOTZE MJ; RAUBENHEIMER EJ
    DETECTION OF P53 GENE-MUTATIONS IN ORAL SQUAMOUS-CELL CARCINOMAS OF ABLACK-AFRICAN POPULATION-SAMPLE
    Human mutation
    
    E.J. Vanrensburg et al., "DETECTION OF P53 GENE-MUTATIONS IN ORAL SQUAMOUS-CELL CARCINOMAS OF ABLACK-AFRICAN POPULATION-SAMPLE", Human mutation, 11(1), 1998, pp. 39-44
62. Peller, S
    Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response
    SEMINARS IN CANCER BIOLOGY
    
    S. Peller, "Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response", SEM CANC B, 8(5), 1998, pp. 379-387
63. SANCHEZPERNAUTE A; TORRES A; INIESTA P; HERNANDO F; GOMEZ A; GONZALEZ O; DEJUAN C; PEREZAGUIRRE E; MAESTRO ML; LOPEZASENJO JA; BENITO M; BALIBREA JL
    PROGNOSTIC-SIGNIFICANCE OF P53 GENE-MUTATIONS IN SQUAMOUS-CELL CARCINOMA OF THE LUNG
    Oncology Reports
    
    A. Sanchezpernaute et al., "PROGNOSTIC-SIGNIFICANCE OF P53 GENE-MUTATIONS IN SQUAMOUS-CELL CARCINOMA OF THE LUNG", Oncology Reports, 5(5), 1998, pp. 1129-1133
64. Cokgor, I; Friedman, AH; Friedman, HS
    Paediatric update - Gliomas
    EUROPEAN JOURNAL OF CANCER
    
    I. Cokgor et al., "Paediatric update - Gliomas", EUR J CANC, 34(12), 1998, pp. 1910-1915
65. WADDELL S; JENKINS JR
    DEFINING THE MINIMAL REQUIREMENTS FOR PAPILLOMA VIRAL E6-MEDIATED INHIBITION OF HUMAN P53 ACTIVITY IN FISSION YEAST
    Oncogene
    
    S. Waddell e J.R. Jenkins, "DEFINING THE MINIMAL REQUIREMENTS FOR PAPILLOMA VIRAL E6-MEDIATED INHIBITION OF HUMAN P53 ACTIVITY IN FISSION YEAST", Oncogene, 16(13), 1998, pp. 1759-1765
66. FRAZIER ML; INAMDAR N; ALVULA S; WU E; KIM YH
    FEW POINT MUTATIONS IN ELONGATION FACTOR-1-GAMMA GENE IN GASTROINTESTINAL CARCINOMA
    Molecular carcinogenesis
    
    M.L. Frazier et al., "FEW POINT MUTATIONS IN ELONGATION FACTOR-1-GAMMA GENE IN GASTROINTESTINAL CARCINOMA", Molecular carcinogenesis, 22(1), 1998, pp. 9-15
67. HOFFSCHIR F; DAYAGROSJEAN L; PETIT PX; NOCENTINI S; DUTRILLAUX B; SARASIN A; VUILLAUME M
    LOW CATALASE ACTIVITY IN XERODERMA-PIGMENTOSUM FIBROBLASTS AND SV40-TRANSFORMED HUMAN CELL-LINES IS DIRECTLY RELATED TO DECREASED INTRACELLULAR LEVELS OF THE COFACTOR, NADPH
    Free radical biology & medicine
    
    F. Hoffschir et al., "LOW CATALASE ACTIVITY IN XERODERMA-PIGMENTOSUM FIBROBLASTS AND SV40-TRANSFORMED HUMAN CELL-LINES IS DIRECTLY RELATED TO DECREASED INTRACELLULAR LEVELS OF THE COFACTOR, NADPH", Free radical biology & medicine, 24(5), 1998, pp. 809-816
68. DESTANCHINA E; MCCURRACH ME; ZINDY F; SHIEH SY; FERBEYRE G; SAMUELSON AV; PRIVES C; ROUSSEL MF; SHERR CJ; LOWE SW
    E1A SIGNALING TO P53 INVOLVES THE P19(ARF) TUMOR-SUPPRESSOR
    Genes & development
    
    E. Destanchina et al., "E1A SIGNALING TO P53 INVOLVES THE P19(ARF) TUMOR-SUPPRESSOR", Genes & development, 12(15), 1998, pp. 2434-2442
69. ZWACKA RM; DUNLOP MG
    GENE-THERAPY FOR COLON-CANCER
    Hematology/oncology clinics of North America
    
    R.M. Zwacka e M.G. Dunlop, "GENE-THERAPY FOR COLON-CANCER", Hematology/oncology clinics of North America, 12(3), 1998, pp. 595
70. TRUCKENMILLER ME; TORNATORE C; WRIGHT RD; DILLONCARTER O; MEINERS S; GELLER HM; FREED WJ
    A TRUNCATED SV40 LARGE T-ANTIGEN LACKING THE P53 BINDING DOMAIN OVERCOMES P53-INDUCED GROWTH ARREST AND IMMORTALIZES PRIMARY MESENCEPHALIC CELLS
    Cell and tissue research
    
    M.E. Truckenmiller et al., "A TRUNCATED SV40 LARGE T-ANTIGEN LACKING THE P53 BINDING DOMAIN OVERCOMES P53-INDUCED GROWTH ARREST AND IMMORTALIZES PRIMARY MESENCEPHALIC CELLS", Cell and tissue research, 291(2), 1998, pp. 175-189
71. DILLONCARTER O; CONEJERO C; TORNATORE C; POLTORAK M; FREED WJ
    N18-RE-105 CELLS - DIFFERENTIATION AND ACTIVATION OF P53 IN RESPONSE TO GLUTAMATE AND ADRIAMYCIN IS BLOCKED BY SV40 LARGE T-ANTIGEN TSA58
    Cell and tissue research
    
    O. Dilloncarter et al., "N18-RE-105 CELLS - DIFFERENTIATION AND ACTIVATION OF P53 IN RESPONSE TO GLUTAMATE AND ADRIAMYCIN IS BLOCKED BY SV40 LARGE T-ANTIGEN TSA58", Cell and tissue research, 291(2), 1998, pp. 191-205
72. MARIN MC; JOST CA; IRWIN MS; DECAPRIO JA; CAPUT D; KAELIN WG
    VIRAL ONCOPROTEINS DISCRIMINATE BETWEEN P53 AND THE P53 HOMOLOG P73
    Molecular and cellular biology (Print)
    
    M.C. Marin et al., "VIRAL ONCOPROTEINS DISCRIMINATE BETWEEN P53 AND THE P53 HOMOLOG P73", Molecular and cellular biology (Print), 18(11), 1998, pp. 6316-6324
73. Reddel, RR
    A reassessment of the telomere hypothesis of senescence
    BIOESSAYS
    
    R.R. Reddel, "A reassessment of the telomere hypothesis of senescence", BIOESSAYS, 20(12), 1998, pp. 977-984
74. BROWN DR; THOMAS CA; DEB SP
    THE HUMAN ONCOPROTEIN MDM2 ARRESTS THE CELL-CYCLE - ELIMINATION OF ITS CELL-CYCLE-INHIBITORY FUNCTION INDUCES TUMORIGENESIS
    EMBO journal
    
    D.R. Brown et al., "THE HUMAN ONCOPROTEIN MDM2 ARRESTS THE CELL-CYCLE - ELIMINATION OF ITS CELL-CYCLE-INHIBITORY FUNCTION INDUCES TUMORIGENESIS", EMBO journal, 17(9), 1998, pp. 2513-2525
75. RUTZ HP; MARIOTTA M; DOEBERITZ MV; MIRIMANOFF RO
    DEXAMETHASONE-INDUCED RADIORESISTANCE OCCURRING INDEPENDENT OF HUMAN PAPILLOMA-VIRUS GENE-EXPRESSION IN CERVICAL-CARCINOMA CELLS
    Strahlentherapie und Onkologie
    
    H.P. Rutz et al., "DEXAMETHASONE-INDUCED RADIORESISTANCE OCCURRING INDEPENDENT OF HUMAN PAPILLOMA-VIRUS GENE-EXPRESSION IN CERVICAL-CARCINOMA CELLS", Strahlentherapie und Onkologie, 174(2), 1998, pp. 71-74
76. NEWMASTER RS; MYLIN LM; FU TM; TEVETHIA SS
    ROLE OF A SUBDOMINANT H-2K(D)-RESTRICTED SV40 TUMOR-ANTIGEN CYTOTOXICT-LYMPHOCYTE EPITOPE IN TUMOR REJECTION
    Virology
    
    R.S. Newmaster et al., "ROLE OF A SUBDOMINANT H-2K(D)-RESTRICTED SV40 TUMOR-ANTIGEN CYTOTOXICT-LYMPHOCYTE EPITOPE IN TUMOR REJECTION", Virology, 244(2), 1998, pp. 427-441
77. Higashino, F; Pipas, JM; Shenk, T
    Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    F. Higashino et al., "Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73", P NAS US, 95(26), 1998, pp. 15683-15687
78. WU M; BELLAS RE; SHEN J; SONENSHEIN GE
    ROLES OF THE TUMOR-SUPPRESSOR P53 AND THE CYCLIN-DEPENDENT KINASE INHIBITOR P21(WAF1 CTP1) IN RECEPTOR-MEDIATED APOPTOSIS OF WEHI-231 B-LYMPHOMA-CELLS/
    The Journal of experimental medicine
    
    M. Wu et al., "ROLES OF THE TUMOR-SUPPRESSOR P53 AND THE CYCLIN-DEPENDENT KINASE INHIBITOR P21(WAF1 CTP1) IN RECEPTOR-MEDIATED APOPTOSIS OF WEHI-231 B-LYMPHOMA-CELLS/", The Journal of experimental medicine, 187(10), 1998, pp. 1671-1679
79. Gallia, GL; Safak, M; Khalili, K
    Interaction of the single-stranded DNA-binding protein Pur alpha with the human polyomavirus JC virus early protein T-antigen
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    G.L. Gallia et al., "Interaction of the single-stranded DNA-binding protein Pur alpha with the human polyomavirus JC virus early protein T-antigen", J BIOL CHEM, 273(49), 1998, pp. 32662-32669
80. POWELL AJ; GATES PB; WYLIE D; VELLOSO CP; BROCKES JP; JAT PS
    IMMORTALIZATION OF RAT EMBRYO FIBROBLASTS BY A 3'-UNTRANSLATED REGION
    Experimental cell research
    
    A.J. Powell et al., "IMMORTALIZATION OF RAT EMBRYO FIBROBLASTS BY A 3'-UNTRANSLATED REGION", Experimental cell research, 240(2), 1998, pp. 252-262
81. STEELE RJC; THOMPSON AM; HALL PA; LANE DP
    THE P53 TUMOR-SUPPRESSOR GENE
    British Journal of Surgery
    
    R.J.C. Steele et al., "THE P53 TUMOR-SUPPRESSOR GENE", British Journal of Surgery, 85(11), 1998, pp. 1460-1467
82. Monier, R
    DNA tumor viruses: probes for the discovery of tumour suppressor genes
    EUROCANCER 98
    
    R. Monier, "DNA tumor viruses: probes for the discovery of tumour suppressor genes", EUROCANCER 98, 1998, pp. 161-162
83. GALLIMORE PH; LECANE PS; HANN B; GRAND RJA
    DIFFERENTIATION IS INHIBITED AND A SENESCENCE PATHWAY IS ACTIVATED WHEN SIMIAN-VIRUS-40 TSA 58-TRANSFORMED HUMAN RETINOBLASTS ARE GROWN AT THE RESTRICTIVE TEMPERATURE
    Cell growth & differentiation
    
    P.H. Gallimore et al., "DIFFERENTIATION IS INHIBITED AND A SENESCENCE PATHWAY IS ACTIVATED WHEN SIMIAN-VIRUS-40 TSA 58-TRANSFORMED HUMAN RETINOBLASTS ARE GROWN AT THE RESTRICTIVE TEMPERATURE", Cell growth & differentiation, 8(7), 1997, pp. 763-771
84. KOENIG MG; STURM D; PROWALD A; ISSINGER OG; MONTENARH M
    INTERACTION OF P53 WITH PROTEIN-KINASE CK2 DURING SV40 INDUCED ENTRANCE OF QUIESCENT CELLS INTO THE CELL-CYCLE
    International journal of oncology
    
    M.G. Koenig et al., "INTERACTION OF P53 WITH PROTEIN-KINASE CK2 DURING SV40 INDUCED ENTRANCE OF QUIESCENT CELLS INTO THE CELL-CYCLE", International journal of oncology, 10(2), 1997, pp. 405-411
85. LANE DP; HALL PA
    MDM2 - ARBITER OF P53S DESTRUCTION
    Trends in biochemical sciences
    
    D.P. Lane e P.A. Hall, "MDM2 - ARBITER OF P53S DESTRUCTION", Trends in biochemical sciences, 22(10), 1997, pp. 372-374
86. TRUCKENMILLER ME; DILLONCARTER O; TORNATORE C; KULAGA H; TAKASHIMA H; FREED WJ
    GROWTH-PROPERTIES OF NEURAL CELL-LINES IMMORTALIZED WITH THE TSA58 ALLELE OF SV40 LARGE T-ANTIGEN
    Cell transplantation
    
    M.E. Truckenmiller et al., "GROWTH-PROPERTIES OF NEURAL CELL-LINES IMMORTALIZED WITH THE TSA58 ALLELE OF SV40 LARGE T-ANTIGEN", Cell transplantation, 6(3), 1997, pp. 231-238
87. MONTANO X
    P53 ASSOCIATES WITH TRK TYROSINE KINASE
    Oncogene
    
    X. Montano, "P53 ASSOCIATES WITH TRK TYROSINE KINASE", Oncogene, 15(3), 1997, pp. 245-256
88. LINKE SP; HARRIS MP; NEUGEBAUER SE; CLARKIN KC; SHEPARD HM; MANEVAL DC; WAHL GM
    P53-MEDIATED ACCUMULATION OF HYPOPHOSPHORYLATED PRB AFTER THE G(1) RESTRICTION POINT FAILS TO HALT CELL-CYCLE PROGRESSION
    Oncogene
    
    S.P. Linke et al., "P53-MEDIATED ACCUMULATION OF HYPOPHOSPHORYLATED PRB AFTER THE G(1) RESTRICTION POINT FAILS TO HALT CELL-CYCLE PROGRESSION", Oncogene, 15(3), 1997, pp. 337-345
89. BLAGOSKLONNY MV
    LOSS OF FUNCTION AND P53 PROTEIN STABILIZATION
    Oncogene
    
    M.V. Blagosklonny, "LOSS OF FUNCTION AND P53 PROTEIN STABILIZATION", Oncogene, 15(16), 1997, pp. 1889-1893
90. MIDGLEY CA; LANE DP
    P53 PROTEIN STABILITY IN TUMOR-CELLS IS NOT DETERMINED BY MUTATION BUT IS DEPENDENT ON MDM2 BINDING
    Oncogene
    
    C.A. Midgley e D.P. Lane, "P53 PROTEIN STABILITY IN TUMOR-CELLS IS NOT DETERMINED BY MUTATION BUT IS DEPENDENT ON MDM2 BINDING", Oncogene, 15(10), 1997, pp. 1179-1189
91. ONEILL FJ; HU Y; CHEN T; CARNEY H
    IDENTIFICATION OF P53 UNBOUND TO T-ANTIGEN IN HUMAN-CELLS TRANSFORMEDBY SIMIAN-VIRUS-40 T-ANTIGEN
    Oncogene
    
    F.J. Oneill et al., "IDENTIFICATION OF P53 UNBOUND TO T-ANTIGEN IN HUMAN-CELLS TRANSFORMEDBY SIMIAN-VIRUS-40 T-ANTIGEN", Oncogene, 14(8), 1997, pp. 955-965
92. STIEGLER P; SCHUCHNER S; LESTOU V; WINTERSBERGER E
    POLYOMAVIRUS LARGE-T-ANTIGEN-DEPENDENT DNA AMPLIFICATION
    Oncogene
    
    P. Stiegler et al., "POLYOMAVIRUS LARGE-T-ANTIGEN-DEPENDENT DNA AMPLIFICATION", Oncogene, 14(8), 1997, pp. 987-995
93. SIMONS A; MELAMEDBESSUDO C; WOLKOWICZ R; SPERLING J; SPERLING R; EISENBACH L; ROTTER V
    PACT - CLONING AND CHARACTERIZATION OF A CELLULAR P53 BINDING-PROTEINTHAT INTERACTS WITH RB
    Oncogene
    
    A. Simons et al., "PACT - CLONING AND CHARACTERIZATION OF A CELLULAR P53 BINDING-PROTEINTHAT INTERACTS WITH RB", Oncogene, 14(2), 1997, pp. 145-155
94. LOMAX ME; BARNES DM; GILCHRIST R; PICKSLEY SM; VARLEY JM; CAMPLEJOHN RS
    2 FUNCTIONAL ASSAYS EMPLOYED TO DETECT AN UNUSUAL MUTATION IN THE OLIGOMERIZATION DOMAIN OF P53 IN A LI-FRAUMENI LIKE FAMILY
    Oncogene
    
    M.E. Lomax et al., "2 FUNCTIONAL ASSAYS EMPLOYED TO DETECT AN UNUSUAL MUTATION IN THE OLIGOMERIZATION DOMAIN OF P53 IN A LI-FRAUMENI LIKE FAMILY", Oncogene, 14(15), 1997, pp. 1869-1874
95. MURAKAMI SI; UCHIDA Y; TAKENO SS; NOGUCHI T; MATSUMOTO K; SHIMODA H
    EXPRESSION OF PCNA AND P53 IN ESOPHAGEAL DYSPLASIA AND ESOPHAGEAL-CARCINOMA
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    
    S.I. Murakami et al., "EXPRESSION OF PCNA AND P53 IN ESOPHAGEAL DYSPLASIA AND ESOPHAGEAL-CARCINOMA", SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 27(7), 1997, pp. 593-599
96. SHVARTS A; BAZUINE M; DEKKER P; RAMOS YFM; STEEGENGA WT; MERCKX G; VANHAM RCA; VANOORDT WV; VANDEREB AJ; JOCHEMSEN AG
    ISOLATION AND IDENTIFICATION OF THE HUMAN HOMOLOG OF A NEW P53-BINDING PROTEIN, MDMX
    Genomics
    
    A. Shvarts et al., "ISOLATION AND IDENTIFICATION OF THE HUMAN HOMOLOG OF A NEW P53-BINDING PROTEIN, MDMX", Genomics, 43(1), 1997, pp. 34-42
97. BROWN J; HIGO H; MCKALIP A; HERMAN B
    HUMAN PAPILLOMAVIRUS (HPV)-16-E6 SENSITIZES CELLS TO ATRACTYLOSIDE-INDUCED APOPTOSIS - ROLE OF P53, ICE-LIKE PROTEASES AND THE MITOCHONDRIAL PERMEABILITY TRANSITION
    Journal of cellular biochemistry
    
    J. Brown et al., "HUMAN PAPILLOMAVIRUS (HPV)-16-E6 SENSITIZES CELLS TO ATRACTYLOSIDE-INDUCED APOPTOSIS - ROLE OF P53, ICE-LIKE PROTEASES AND THE MITOCHONDRIAL PERMEABILITY TRANSITION", Journal of cellular biochemistry, 66(2), 1997, pp. 245-255
98. WOLKOWICZ R; ROTTER V
    THE DNA-BINDING REGULATORY DOMAIN OF P53 - SEE THE C
    Pathologie et biologie
    
    R. Wolkowicz e V. Rotter, "THE DNA-BINDING REGULATORY DOMAIN OF P53 - SEE THE C", Pathologie et biologie, 45(10), 1997, pp. 785-796
99. MILNER J
    STRUCTURES AND FUNCTIONS OF THE TUMOR-SUPPRESSOR P53
    Pathologie et biologie
    
    J. Milner, "STRUCTURES AND FUNCTIONS OF THE TUMOR-SUPPRESSOR P53", Pathologie et biologie, 45(10), 1997, pp. 797-803
100. PUISIEUX A; OZTURK M
     TP53 AND HEPATOCELLULAR-CARCINOMA
     Pathologie et biologie
     
     A. Puisieux e M. Ozturk, "TP53 AND HEPATOCELLULAR-CARCINOMA", Pathologie et biologie, 45(10), 1997, pp. 864-870